Emtricitabine and blood alkaline phosphatase increased Patient Reports February 09, 2010
Emtricitabine Side Effects Report #4676809-6
Emtricitabine side effect was reported by a Consumer or non-health professional from on May 12, 2005. Female patient, 43 years of age, weighting 168.0 lb, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, eructation, fatigue, gamma-glutamyltransferase increased, hepatic steatosis. Emtricitabine dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with LOPINAVIR, BACTRIM DS, LISINOPRIL, ASPIRIN, GLUCOPHAGE, TRICOR, NOVOLIN. Patient was hospitalized. Patient recovered.Emtricitabine Side Effects Report #5320735-6
Emtricitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2007. Male patient, 32 years of age, weighting 115.1 lb, was diagnosed with hiv infection
, prophylaxis and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: abdominal pain upper, band neutrophil percentage increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood phosphorus increased, blood potassium decreased, cough. Emtricitabine dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, VITAMIN CAP, ASCORBIC ACID, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient was hospitalized. Patient recovered.Emtricitabine Side Effects Report #5162498-3
Emtricitabine side effect was reported by a Health Professional from UNITED STATES on Nov 28, 2006. Male patient, 31 years of age, weighting 131.8 lb, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: abdominal discomfort, acid fast bacilli infection, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, chest pain
, confusional state. Emtricitabine dosage: 200 MG Q HS PO. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, COTRIM D, ISONIAZID, RIFAMPICIN, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Emtricitabine Side Effects Report #4610469-5
Emtricitabine side effect was reported by a Consumer or non-health professional from on Mar 01, 2005. Male patient, 14 years of age, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood amylase increased, blood bilirubin increased, blood bilirubin unconjugated increased, condition aggravated, fatigue, gamma-glutamyltransferase increased. Emtricitabine dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ATAZANAVIR, RITONAVIR, DIDANOSINE. Patient recovered.Emtricitabine Side Effects Report #4650869-0
Emtricitabine side effect was reported by a Consumer or non-health professional from on Apr 18, 2005. Male patient, 14 years of age, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood amylase increased, blood bilirubin increased, blood bilirubin unconjugated increased, fatigue, gamma-glutamyltransferase increased, glucose urine present. Emtricitabine dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ATAZANAVIR, RITONAVIR, DIDANOSINE. Patient recovered.Emtricitabine Side Effects Report #5976237-7
Emtricitabine side effect was reported by a Consumer or non-health professional from LIBYAN ARAB JAMAHIRIYA on Nov 19, 2008. Male patient, child 12 years of age, was diagnosed with hiv infection
and was treated with Emtricitabine. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, fanconi syndrome acquired, osteopenia, paraesthesia, rickets
. Emtricitabine dosage: unknown. During the same period patient was treated with LOPINAVIR AND RITONAVIR. Patient recovered.
Emtricitabine and blood alkaline phosphatase increased 